NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/16/2024
Back to search
Official data from USPTO
BIOSIMILARS REVIEW & REPORT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIOSIMILARS REVIEW & REPORT
ST13
US500000098054777Class
41
Filing
98054777
Registration
7361923
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
10
Latest update
04/16/2024
Trademark type
Word
Nice classes
41
Filing date
06/22/2023
Registration date
04/16/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/16/2024
Last transaction
04/16/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
First use anywhere
12/01/2015
First use in commerce
03/15/2016
Drawing code
4
Owner type
16
Owner location
Newtown, PA
Examiner
BULLOFF, TOBY ELLEN
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SM Health Communications, LLC
Representatives
SM HEALTH COMMUNICATIONS, LLC
Technical classification
Nice Classes
Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
On-line journalsblogs featuring biosimilarbiologics news and commentary; Online publication of blogs; Providing a website featuring blogs and non-downloadable publications in the nature of articlesreportsdatabases in the field(s) of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
10 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
04/16/2024
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
03/11/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
03/11/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/11/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
03/11/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/11/2024
DOCK
ASSIGNED TO EXAMINER
03/10/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/25/2023
NWAP
NEW APPLICATION ENTERED
06/26/2023
Continuous trademark protection
Get notified about every new filing that threatens BIOSIMILARS REVIEW & REPORT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.